A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma

por Tiako Meyo, Manuela, Chen, Jeanne, Goldwasser, Francois, Hirsch, Laure, Huillard, Olivier
Publicado 2022

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study

por Salimon, Maëva, Prieux-Klotz, Caroline, Tougeron, David, Hautefeuille, Vincent, Caulet, Morgane, Gournay, Jérôme, Matysiak-Budnik, Tamara, Bennouna, Jaafar, Tiako Meyo, Manuela, Lecomte, Thierry, Zaanan, Aziz, Touchefeu, Yann
Publicado 2018

Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

por Noé, Gaëlle, Bellesoeur, Audrey, Golmard, Lisa, Thomas-Schoemann, Audrey, Boudou-Rouquette, Pascaline, Tiako Meyo, Manuela, Puszkiel, Alicja, Arrondeau, Jennifer, Alexandre, Jérome, Goldwasser, François, Blanchet, Benoit, Vidal, Michel
Publicado 2019

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

por Tiako Meyo, Manuela, Jouinot, Anne, Giroux-Leprieur, Etienne, Fabre, Elizabeth, Wislez, Marie, Alifano, Marco, Leroy, Karen, Boudou-Rouquette, Pascaline, Tlemsani, Camille, Khoudour, Nihel, Arrondeau, Jennifer, Thomas-Schoemann, Audrey, Blons, Hélène, Mansuet-Lupo, Audrey, Damotte, Diane, Vidal, Michel, Goldwasser, François, Alexandre, Jérôme, Blanchet, Benoit
Publicado 2020